Season finale alert! 🚨
We're diving into a cutting-edge breakthrough in gut health: Fecal Microbiota transplants (FMT) with an innovative new product soon hitting the market.
Host Ariadna Masó (SANNO founder & CEO) speaks with Patricia del Rio, Director of Business Development at Mikrobiomik, a pioneering biopharma company focused on microbiome-based therapies.
Patricia shares the science behind their FMT capsules, tackling antibiotic resistance and revolutionizing patient care.
Tune in to learn about:
The fascinating world of the fecal microbiome 🦠
How FMTs are reshaping treatment for Clostridioides difficile.
Challenges and promises of microbiome-based therapies 🚀
Get ready to discover how innovation is changing the future of gut health! 🎙️
#GutHealth #Microbiome #FecalMicrobiotaTransplant #HealthInnovation #ClinicalTrials #Healthcare #MicrobiomeTherapies #Podcast #PatientCare #FutureOfMedicine
